within Pharmacolibrary.Drugs.ATC.N;

model N03AG06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.11 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 30 / 1000000,
    adminCount     = 1,
    Vd             = 0.0009,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Tiagabine is an anticonvulsant medication primarily used as an adjunctive therapy in the treatment of partial seizures in epilepsy. It works by inhibiting the reuptake of gamma-aminobutyric acid (GABA) in the brain, thereby increasing the availability of this inhibitory neurotransmitter. Tiagabine is approved for clinical use and is typically administered orally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers receiving single oral doses.</p><h4>References</h4><ol><li><p> (2024). Comparison Table: Some oral antiseizure medications. <i>The Medical letter on drugs and therapeutics</i> 66(1708) e133–e140. DOI:<a href=&quot;https://doi.org/10.58347/tml.2024.1708b&quot;>10.58347/tml.2024.1708b</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39073881/&quot;>https://pubmed.ncbi.nlm.nih.gov/39073881</a></p></li><li><p>Jacob, S, &amp; Nair, AB (2016). An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs. <i>Drugs in R&amp;D</i> 16(4) 303–316. DOI:<a href=&quot;https://doi.org/10.1007/s40268-016-0148-6&quot;>10.1007/s40268-016-0148-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27766590/&quot;>https://pubmed.ncbi.nlm.nih.gov/27766590</a></p></li><li><p>Kälviäinen, R (1998). Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy. <i>Journal of intellectual disability research : JIDR</i> 42 Suppl 1 63–67. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10030435/&quot;>https://pubmed.ncbi.nlm.nih.gov/10030435</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N03AG06;
